Cleartext Archiving Vulnerability in TeleMessage TM SGNL

Historical catalog analysis: CISA added this entry on May 12, 2025. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. Check current vendor guidance before acting.

What the vulnerability is

CVE-2025-47729 describes a hidden functionality vulnerability (CWE-912) within TeleMessage TM SGNL. The flaw exists in the archiving backend, which stores cleartext copies of messages sent by application users. For healthcare organizations utilizing this platform for secure communication, this represents a critical failure in data encryption at rest, as sensitive patient information intended to be secure may be stored in an unencrypted format within the archive.

Exposure and applicability

This vulnerability applies to healthcare providers, health plans, and business associates using TeleMessage TM SGNL for the transmission of electronic Protected Health Information (ePHI). Because the archiving backend holds cleartext copies of messages, any unauthorized access to that backend—or any administrative oversight regarding archive security—could lead to the exposure of sensitive clinical data. This directly impacts the confidentiality requirements of the HIPAA Security Rule regarding the protection of ePHI during storage.

Remediation priorities

Based on our analysis of the reported flaw, we recommend the following prioritized actions for security leaders and IT administrators:

1. Vendor Mitigation Review: Immediately identify if your organization is using TM SGNL and determine if vendor-provided mitigations have been applied. This is the primary step to reduce the likelihood of cleartext exposure.
2. Cloud Service Audit: For organizations utilizing this as a cloud service, review configurations in alignment with guidance similar to BOD 22-01 to ensure that the archiving environment is isolated and access is strictly controlled.
3. Usage Evaluation: In scenarios where vendor mitigations are unavailable or cannot be verified, our analysis suggests evaluating the discontinuation of the product to prevent further exposure of ePHI.

How to validate remediation

Validation should focus on confirming the status of the archiving mechanism rather than attempting to access the backend directly. We recommend:
* Configuration Verification: The IT administrator or security officer should document the specific version and mitigation patch level applied, verified against official vendor release notes.
* Vendor Attestation: Request formal confirmation from the service provider that cleartext archiving has been disabled or remediated for your specific instance.

Note: Security teams should avoid intrusive testing of the archiving backend without explicit vendor authorization to prevent operational disruptions.

Limits and open questions

It remains unclear exactly how this hidden functionality was implemented or if it was an intentional design choice that became a vulnerability. While CISA has added this to the Known Exploited Vulnerabilities catalog, specific details regarding active campaigns targeting healthcare entities are not provided in the source. Furthermore, applying mitigations may reduce the risk of cleartext exposure, but residual risks associated with the overall architecture of the archiving backend may persist.

Source and editorial note

CVE-2025-47729: TeleMessage TM SGNL Hidden Functionality Vulnerability · Source date: May 12, 2025 · Retrieved August 31, 2026.

Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.

Archive date: May 15, 2025. The displayed post date is assigned three days after the source date to organize this retrospective archive; it does not mean this site published the analysis then. First published by this site: October 12, 2026 at 01:13 UTC.

Request a healthcare security assessment